190 related articles for article (PubMed ID: 15456515)
1. Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis.
Colombet I; Bura-Rivière A; Chatila R; Chatellier G; Durieux P;
BMC Health Serv Res; 2004 Sep; 4(1):27. PubMed ID: 15456515
[TBL] [Abstract][Full Text] [Related]
2. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
[No Abstract] [Full Text] [Related]
3. [Treatment of venous thrombosis with low molecular weight heparin and fluindione].
Fiessinger JN; Paul JF; Alhenc-Gelas M; Veyssier C; Martin JB; Aiach M
Presse Med; 1992 Jan; 21(2):65-8. PubMed ID: 1311080
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
6. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
[TBL] [Abstract][Full Text] [Related]
7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
8. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders.
Palen TE; Raebel M; Lyons E; Magid DM
Am J Manag Care; 2006 Jul; 12(7):389-95. PubMed ID: 16834525
[TBL] [Abstract][Full Text] [Related]
10. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial.
Strom BL; Schinnar R; Aberra F; Bilker W; Hennessy S; Leonard CE; Pifer E
Arch Intern Med; 2010 Sep; 170(17):1578-83. PubMed ID: 20876410
[TBL] [Abstract][Full Text] [Related]
11. Practical application of the 10-mg warfarin initiation nomogram.
Wells PS; Le Gal G; Tierney S; Carrier M
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
[TBL] [Abstract][Full Text] [Related]
12. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
[TBL] [Abstract][Full Text] [Related]
13. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
14. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
15. Interaction between hormone replacement therapy preparations and oral anticoagulant therapy.
McLintock LA; Dykes A; Tait RC; Walker ID
BJOG; 2003 Aug; 110(8):777-9. PubMed ID: 12892692
[TBL] [Abstract][Full Text] [Related]
16. Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system.
Lin SW; Kang WY; Lin DT; Lee J; Wu FL; Chen CL; Tseng YJ
BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S13. PubMed ID: 25079609
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
Levine M
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
[TBL] [Abstract][Full Text] [Related]
18. Successful computerized physician order entry system implementation. Tools to support physician-driven design and adoption.
Williams RB
Healthc Leadersh Manag Rep; 2002 Oct; 10(10):1-13. PubMed ID: 12506440
[No Abstract] [Full Text] [Related]
19. Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group.
Leroyer C; Bressollette L; Oger E; Mansourati J; Chèze-Le Rest C; Nonent M; Buchmuller A; Tardy B; Decousus H; Parent F; Simonneau G; Juste K; Ill P; Abgrall JF; Clavier J; Mottier D
Haemostasis; 1998; 28(2):70-7. PubMed ID: 10087431
[TBL] [Abstract][Full Text] [Related]
20. Predicting daily maintenance dose of fluindione, an oral anticoagulant drug.
Cazaux V; Gauthier B; Elias A; Lefebvre D; Tredez J; Nguyen F; Cambus JP; Boneu B; Boccalon H
Thromb Haemost; 1996 May; 75(5):731-3. PubMed ID: 8725714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
